Open Call HORIZON-EIC-2022-PATHFINDERCHALLENGES-01-05: DNA-Based Digital Data Storage

European Commission Current technologies for digital data storage are hitting sustainability limits in terms of energy consumption and their use of rare and toxic materials. Moreover, data integrity when using those technologies is limited in time, which complicates archival data-storage. DNA or certain classes of synthetic DNA alternatives provide an alternative that promises information densities that are several orders of magnitude higher than classical memories, and stability for millennia rather than years. Moreover, DNA-based data storage can profit from the growing range of DNA research, tools and techniques from the life sciences, while potentially also adding to it (e.g., for in-vivo data collection).

Proof of concept for DNA data archiving in vitro (i.e. not in living cells) is now well established. Several studies have shown that such archiving can support selective and scalable access to data, as well as error-free storage and retrieval of information. However, technical challenges remain to make this process economically viable for a broad spectrum of uses (beyond so-called 'cold data') and data types. These relate to improving the cost, speed and efficiency of technologies for reading, and especially writing and editing, DNA or other information-storing bio-polymers.

Large corporates and governments are starting to show an interest and some smaller companies offer solutions for specific archival applications. Europe has academic and commercial potential in this area. The time is right to pull together a European R&I ecosystem on DNA-based digital data storage.

This EIC Pathfinder Challenge is to explore scalable and reliable high-throughput approaches for using DNA as a general data-storage medium. Solutions would thus need to address the read/write/edit operations of digital data in synthetic DNA, capturing the expected advantages of high density and stability/longevity of this form of data storage. The use of DNA sequences as chassis for non-standard forms of information coding, or of other polymeric substrates and related coding/decoding techniques are also in scope, provided they entail at least similar benefits than state-of-the-art DNA approaches. Proposed techniques should deliver qualitative advances in key parameters such as throughput, DNA-length (well above a few hundred mers), reliability (coupling efficiency), speed and cost. Beyond the usual storage applications, there is also scope for radically different scenarios for such a technology, for instance for data-processing, in-vivo sensing or fingerprinting.

Applications submitted to this Challenge, must pay particular attention to the relevant bio-safety and ethical issues.

Opening date: 16 June 2022

Deadline: 19 October 2022 17:00:00 Brussels time

Deadline Model: single-stage

Type of action: HORIZON-EIC HORIZON EIC Grants

For topic conditions, documents and submission service, please visit:
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-eic-2022-pathfinderchallenges-01-05

Most Popular Now

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

ChatGPT Performs as Well as Doctors for …

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...

AI may Outperform Most Humans at Creativ…

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

AI and Machine Learning can Successfully…

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and...